“Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model” (2013) Farmeconomia. Health economics and therapeutic pathways, 14(2), pp. 51–74. doi:10.7175/fe.v14i2.651.